| |
PRZOOM - /newswire/ -
Osaka, Japan, 2025/07/29 - Ono Pharmaceutical Co., Ltd announced its selection by CDP, a global environmental non-profit organization, as an A-List company - CDP.net / ONO-Pharma.com.
|
| |
Ono Pharmaceutical Co., Ltd (Headquarters: Osaka, Japan; President and COO: Toichi Takino,“Ono”) announced its selection by CDP, a global environmental non-profit organization, as an A-List company. Ono earned the highest ranking in the CDP 2024 assessment in two categories for its actions taken to mitigate climate change and promote water security. Ono achieved A-List status in the climate change category for the seventh consecutive year and in the water security category for the fourth consecutive year.
Ono believes the conservation of a rich global environment for future generations is an important foundation for sustainable management for the next 100 years. Based on its medium- and long-term environmental vision, ECO VISION 2050, Ono has committed to reducing greenhouse gas emissions, water consumption, waste associated with its business activities, and its impact on biodiversity. To accelerate efforts to address these environmental issues, Ono has established medium- and long-term environmental targets and is implementing a variety of initiatives.
Ono continues to contribute to people’s health by discovering and developing innovative pharmaceutical products and by promoting initiatives to conserve the global environment for future generations in cooperation with our business partners.
About CDP
CDP (cdp.net) is an international non-profit organization that operates a global environmental disclosure system for companies and local governments. Founded in the UK in 2000, CDP has worked with many investors to pioneer corporate environmental disclosure, reduce greenhouse gas emissions, safeguard water resources and protect forests through capital markets and corporate procurement activities. Currently, CDP has collaborated with over 640 financial institutions with over US$127 trillion in assets. More than 24,800 companies - equal to two-thirds of global market capitalization - and over 1,000 local governments disclosed data through CDP in 2024. CDP is currently one of the most informative disclosure platforms in the world on environmental issues.
About CDP’s scoring
CDP’s annual environmental disclosure and evaluation process is widely recognized as the gold standard of corporate environmental transparency. By encouraging major companies around the world to disclose information about their efforts to address environmental issues and evaluating them, CDP aims to improve engagement in environmental issues worldwide.
A detailed and independent methodology is used by CDP to assess companies, allocating a score of A to D-based on the comprehensiveness of their disclosures, awareness and management of environmental risks, and demonstration of best practices associated with environmental leadership, such as setting ambitious and meaningful targets. Companies that do not disclose or provide insufficient information are given an F.
About Ono Pharmaceutical Co., Ltd
Ono Pharmaceutical Co., Ltd (ono-pharma.com) delivers innovative therapies for patients worldwide. Upholding its philosophy of “Dedicated to the Fight against Disease and Pain,” Ono targets areas with unmet medical needs including oncology, immunology, and neurology, and fosters partnerships with academic and biotech organizations to accelerate drug discovery. Through its affiliate, Deciphera Pharmaceuticals, Ono is accelerating clinical development and commercial operations in the US and Europe to drive global business expansion and further its commitment to patient care.
|
public_relations[.]ono-pharma.com 
